secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cosmos Health Inc. (COSM)
CIK:        0001474167
Form:       8-K
Filed at:   2026-04-16T23:59:59+00:00
Accession:  0001477932-26-002316
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cosmos Health reports record FY2025 revenue $65.3M, up 20%; gross profit +83%, adjusted EPS improves 82%
--------------------------------------------------------------------------------

- Revenue $65.3M (+20% YoY); gross profit $7.9M (+83%); gross margin 12.1% (+418 bps).
- Adjusted EPS improved to ($0.12) from ($0.65) (+82%); adjusted EBITDA loss narrowed to $3.36M.
- Cash and equivalents $3.5M, up 10x from $0.3M; total assets $65.5M (+21%).
- CEO Greg Siokas increased ownership by 3.3M shares; secured $300M digital asset financing facility.
- Contract manufacturing deals for 12M+ units; Sky Premium Life 60 new SKUs; U.S. expansion with NOOR Collagen.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1474167/000147793226002316/0001477932-26-002316-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1474167/000147793226002316/cosm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-002316

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer